Arcadia Biosciences (RKDA) Receives Daily Coverage Optimism Rating of 0.15
Headlines about Arcadia Biosciences (NASDAQ:RKDA) have been trending somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Arcadia Biosciences earned a daily sentiment score of 0.15 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 46.0599388389477 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.
Arcadia Biosciences (NASDAQ:RKDA) opened at $0.26 on Wednesday. Arcadia Biosciences has a twelve month low of $0.23 and a twelve month high of $1.50.
Separately, Piper Jaffray Companies set a $1.00 target price on Arcadia Biosciences and gave the company a “hold” rating in a report on Saturday, July 22nd.
About Arcadia Biosciences
Arcadia Biosciences, Inc is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.
Receive News & Ratings for Arcadia Biosciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.